These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical types of proarrhythmic response to antiarrhythmic drugs. Bigger JT; Sahar DI Am J Cardiol; 1987 Apr; 59(11):2E-9E. PubMed ID: 3554950 [TBL] [Abstract][Full Text] [Related]
3. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects]. Steinbeck G Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290 [TBL] [Abstract][Full Text] [Related]
4. Proarrhythmic actions of antiarrhythmic drugs: a review. Campbell TJ Aust N Z J Med; 1990 Jun; 20(3):275-82. PubMed ID: 2196873 [TBL] [Abstract][Full Text] [Related]
6. [The pro-arrhythmic effects of anti-arrhythmia agents]. Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949 [TBL] [Abstract][Full Text] [Related]
7. The proarrhythmic effects of antiarrhythmic drugs. Creamer JE; Nathan AW; Camm AJ Am Heart J; 1987 Aug; 114(2):397-406. PubMed ID: 3604898 [TBL] [Abstract][Full Text] [Related]
8. Adverse cardiovascular effects of anti-arrhythmia drugs. Part I: Proarrhythmic effects. Libersa C; Caron J; Guedon-Moreau L; Adamantidis M; Nisse C Therapie; 1992; 47(3):193-8. PubMed ID: 1295120 [TBL] [Abstract][Full Text] [Related]
9. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. Hohnloser SH Am J Cardiol; 1997 Oct; 80(8A):82G-89G. PubMed ID: 9354415 [TBL] [Abstract][Full Text] [Related]
10. [Risks and side effects in treatment of supraventricular tachycardia]. Lüderitz B Z Gesamte Inn Med; 1993 Sep; 48(9):459-65. PubMed ID: 8212752 [TBL] [Abstract][Full Text] [Related]
11. The new antiarrhythmic drugs. How to put them to the best use. Anderson JL Postgrad Med; 1988 Mar; 83(4):181-93. PubMed ID: 3353335 [TBL] [Abstract][Full Text] [Related]
12. Proarrhythmic effects of antiarrhythmic drugs. Ross DL; Cooper MJ; Koo CC; Skinner MP; Davis LM; Richards DA; Uther JB Med J Aust; 1990 Jul; 153(1):37-47. PubMed ID: 2199804 [TBL] [Abstract][Full Text] [Related]
13. The clinical use of class IC antiarrhythmic drugs. Abi Samra F J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646 [TBL] [Abstract][Full Text] [Related]
14. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Lazzara R Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326 [TBL] [Abstract][Full Text] [Related]
15. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
16. Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. Hohnloser SH; Singh BN J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):920-36. PubMed ID: 8548113 [TBL] [Abstract][Full Text] [Related]
18. Early and late proarrhythmia from antiarrhythmic drug therapy. Morganroth J Cardiovasc Drugs Ther; 1992 Feb; 6(1):11-4. PubMed ID: 1533532 [TBL] [Abstract][Full Text] [Related]
19. Proarrhythmia in patients treated for atrial fibrillation or flutter. Falk RH Ann Intern Med; 1992 Jul; 117(2):141-50. PubMed ID: 1605429 [TBL] [Abstract][Full Text] [Related]
20. [Cardiac side effects of anti-arrhythmia agents]. Seipel L Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]